Quantcast

Zoloft Lawsuits: Bernstein Liebhard LLP Notes Scheduling of Next Status Conference in Federal Zoloft Birth Defect Litigation

March 24, 2013

The Firm is currently investigating Zoloft lawsuits on behalf of victims of alleged Zoloft birth defects.

New York, New York (PRWEB) March 24, 2013

Bernstein Liebhard LLP notes that the federal judge overseeing Zoloft lawsuits in U.S. District Court, Eastern District of Pennsylvania has issued Pretrial Order Number 18, posted on the court’s website, which sets the litigation´s next status conference for April 2nd at 10:00 a.m. Court records indicate that at least 250 claims have been filed in the consolidated litigation on behalf of alleged victims of Zoloft birth defects. (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation – MDL 2342)

“We are pleased to see these cases moving forward. We continue to receive inquiries from families whose children were born with birth defects that could be associated with their mother´s use of Zoloft during pregnancy,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Zoloft lawsuit consultations to victims of birth defects allegedly associated with the drug.

Zoloft Birth Defects

All of the Zoloft lawsuits pending in the Eastern District of Pennsylvania allege that use of Zoloft during pregnancy can increase the risk of delivering a child with severe birth defects, including pulmonary hypertension in newborns (PPHN), spina bifida and other neural tube defects, heart defects, abdominal defects, and club foot. Court documents indicate the litigation´s first trials are scheduled to begin in October 2014.

Zoloft is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat major depression, obsessive-compulsive disorder, panic disorder, and anxiety disorders. In November 2006, the FDA added warnings about a potential risk of persistent pulmonary hypertension in newborns (PPHN) from Zoloft and other SSRI antidepressants when taken after the 20th week of pregnancy.* A second study published in the British Medical Journal in September 2009 found that SSRI antidepressants like Zoloft increase the risk of heart defects when taken during the first trimester.**

Victims of possible Zoloft birth defects may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. To learn more about alleged Zoloft lawsuits, please visit Bernstein Liebhard LLP´s website. For additional information, contact a lawyer at Bernstein Liebhard LLP today by calling (877) 779-1414.

*fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126522.htm

** bmj.com/content/339/bmj.b3569

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:

Felecia L. Stern, Esq.

Bernstein Liebhard LLP

info(at)consumerinjurylawyers(dot)com

http://www.consumerinjurylawyers.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebzoloft-lawsuits/zoloft-birth-defects/prweb10564346.htm


Source: prweb



comments powered by Disqus